Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-28 ¸ñ 19:46
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 22°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
Áø´Ü¡¤Ä¡·á °ø¹é ¾È°í 3ÃÊ¿¡ 1°Ç¾¿ °ñÀý ¹ß»ý
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:46
[Sub Story]
°í·É»çȸ¸¦ ¹öÆ¿ ¡®Ã࡯ÀÌ À§ÇèÇÏ´Ù
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:44
[Sub Story]
Áõ°¡ÇÏ´Â À¯º´·ü, °¡¶ó¾ÉÀº Ä¡·áÀ²
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:37
[Sub Story]
°ñ´Ù°øÁõ¼º °ñÀý ¿¹¹æ¿¡ ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ® °Á¶
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:24
[Sub Story]
ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ® 1Â÷Àü·«, ÃÖÀå 5³â±îÁö
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:20
¶óÀÎ
[Sub Story]
°ñÀý Àç¹ß¿¹¹æ¿¡ ¾à¹°¿ä¹ý °Á¶
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:15
[Sub Story]
¡®¾à¹°ÈÞÁö±â¡¯·Î ¾àÁ¦ °ü·Ã °ñÀý¿¹¹æ
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:12
[Sub Story]
DMARD Á¶ÇÕÀ¸·Î Ä¡·á¹ÝÀÀ À¯Áö °Á¶
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:06
[Sub Story]
Á¶±âÁø´Ü ¿ä¿øÇÑ ±¹³» ·ù¸¶Æ¼½º°üÀý¿°
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 17:01
[Sub Story]
ÃʱâºÎÅÍ ·ù¸¶Æ¼½º Àü¹®ÀÇ°¡ °ü¸®
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 16:02
¶óÀÎ
[Sub Story]
°ÇÃÊ¿° Áö¼Ó½Ã ·ù¸¶Æ¼½ºÀü¹®ÀÇ¿¡°Ô
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 15:49
[Sub Story]
'´Ü¼ø³ëÈ'°¡ ¾Æ´Ñ '°üÀýÁúȯ'
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 15:37
[Sub Story]
ÅëÇÕÀû Æò°¡¸¦ ÅëÇÑ Ä¡·áÀü·« ±¸¼º
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 15:34
[Sub Story]
°í°üÀý¡¤¹«¸ °ñ°üÀý¿°, NSAID·Î °ü¸®ÇÑ´Ù
ÀÓ¼¼Çü ±âÀÚ
2018-05-03 15:30
[Sub Story]
ACC¡¤AHA, ³ëÀÎ ¼öÃà±âÇ÷¾Ð 130mmHg ¹Ì¸¸Á¶Àý ÆÄ°Ý ±Ç°í
ÀÌ»óµ· ±âÀÚ
2018-05-03 15:04
¶óÀÎ
[Sub Story]
50¼¼ ÀÌ»ó 2¸í Áß 1¸í ÀÌ»óÁöÁúÇ÷Áõ
ÀÌ»óµ· ±âÀÚ
2018-05-03 14:59
[Sub Story]
¡°Æó°æÈ£¸£¸ó¿ä¹ý, ºü¸¦¼ö·Ï µ¿¸Æ°æÈ Áö¿¬È¿°ú¡±
ÀÌ»óµ· ±âÀÚ
2018-05-03 14:57
[Sub Story]
³ëÀÎ ´ç´¢º´ °ü¸®, ÀúÇ÷´çÁõ À§Çè ³·Ãß°í Ç÷´çÁ¶Àý ±Ø´ëÈ
ÀÌ»óµ· ±âÀÚ
2018-05-03 14:48
[Interview]
ÁÖÀÔ¼± ÀÖ°í Å« Àν¶¸° ÆßÇÁ´Â ¿¾¸», ¼ÒÇü¡¤°£Æí¡¤½º¸¶Æ® ±â¼ú·Î »õ ¿ª»ç °³Ã´
ÀÌ»óµ· ±âÀÚ
2018-05-03 14:27
[Late Breaking Studies]
¾Æ´Þ¸®¹«¸¿, ·ù¸¶Æ¼½º°üÀý¿° Ÿ±êÄ¡·á¿¡ È¿°ú
ÀÌ»óµ· ±âÀÚ
2018-05-03 14:23
-
1
2
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top